OH HB183

Codifies 35 specific genetic, endocrine, and metabolic disorders that hospitals and freestanding birthing centers must screen for in newborns, including phenylketonuria, cystic fibrosis, sickle cell disease, and congenital hypothyroidism.

Replaces the previous rule-making authority with statutory requirements, removing the director of health's power to adopt rules specifying screened disorders and instead listing all required disorders directly in law.

Creates a 14-member newborn screening advisory council appointed by the director to advise on screening requirements and provide recommendations regarding genetic, endocrine, and metabolic disorder screenings.

Establishes a minimum $14 screening fee with at least $10.25 going to a genetics services fund and at least $3.75 going to a sickle cell fund to support related health programs.

Declares the bill an emergency measure citing the need for early detection of serious newborn disorders that can prevent brain damage, organ damage, and death.